Charles River Laboratories (CRL) Tops Q1 EPS by 19c; raises guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $317.76 -2.61%
Financial Fact:
Income from continuing operations before income taxes: 53.26M
Today's EPS Names:
KELYA, ROX, KEEL, More
Financial Fact:
Income from continuing operations before income taxes: 53.26M
Today's EPS Names:
KELYA, ROX, KEEL, More
Join SI Premium – FREE
Charles River Laboratories (NYSE: CRL) reported Q1 EPS of $2.78, $0.19 better than the analyst estimate of $2.59. Revenue for the quarter came in at $1.03 billion versus the consensus estimate of $986.31 million.
GUIDANCE:
Charles River Laboratories sees FY2023 EPS of $9.90-$10.90, versus the consensus of $10.24.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Becton Dickinson (BDX) Tops Q4 EPS by 8c; Offers Guidance
- Tecnoglass (TGLS) Tops Q3 EPS by 2c ; Offers Guidance
- Loar Holdings Inc. (LOAR) Reports Q3 EPS of $0.39 ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
